Conventional vs. hypofractionated radiotherapy for high-risk prostate cancer (PCS5), randomized, non-inferiority, phase III trial: Post hoc analysis of radiation therapy toxicities and efficacy of IMRT compared to 3D-CRT

Read full text Summarise with VIRAT
Authors: Constanza Martínez, Steven Tisseverasinghe, Muneeb Uddin Karim, Kanta Ka, Abdenour Nabid, Edmond Kaldany, Rédouane Bettahar, Linda Suzanne Vincent, André-Guy Martin, Marjory Jolicoeur, Michael Yassa, Maroie Barkati
+5 more Boris Bahoric, Robert Archambault, Hugo Villeneuve, M. Mohiuddin, Tamim Mohammad Niazi
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Advanced Radiotherapy Techniques Breast Cancer Treatment Studies

Publication details

Journal / source
Radiotherapy and Oncology
Volume
219
Pages
111490–111490
Publication date
27 March 2026
Language
EN